A novel study into ice-binding proteins has unveiled how antifreeze proteins could be utilized to mitigate cryogenic damage during organ storage. The method could revolutionize organ freezing techniques, and help alleviate organ shortages for the millions of people worldwide who are awaiting a transplant.
Cryogenic has long presented challenges to effective organ preservation, hindering advancements in transplantation and related fields. The inability to effectively preserve organs leads to ice crystal formation and subsequent damage. Ultimately these damaged organs are discarded, leading to an organ shortage.
Despite these challenges, new research published in Langmuir points to a solution that utilizes antifreeze proteins (AFPs) to mitigate cryogenic damage. Utilizing Cryomicroscopy and advanced imaging analysis techniques, researchers tested various antifreeze proteins including AFPIII from fish and TmAFP from the larvae of flour beetles. During testing the team successfully influenced devitrification and delayed crystalization even at temperatures as low as -80 degrees Celsius.
"This advancement opens doors to a new era in tissue preservation and organ transplantation," said Prof. Ido Braslavsky. "With further development, we envision longer preservation periods, enhanced quality during transport, and innovative transplant procedures, including complex organ combinations like heart-lung transplants and uterine tissue transplants."
The findings of the study could revolutionize the field of tissue preservation by increasing organ availability and extending preservation windows.